Screener
Neurocrine Biosciences NBIX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $13.22B.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
FAQ
- What is Neurocrine Biosciences's market capitalization?
- Neurocrine Biosciences (NBIX) reported market capitalization of $13.22B in Q1 2026.
- How has Neurocrine Biosciences's market capitalization changed year-over-year?
- Neurocrine Biosciences's market capitalization increased by 19.9% year-over-year, from $11.03B to $13.22B.
- What is the long-term trend for Neurocrine Biosciences's market capitalization?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's market capitalization has grown at a 9.2% compound annual growth rate (CAGR), from $9.09B to $14.14B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Neurocrine Biosciences's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude